Literature DB >> 27173066

Smaller-Sized Expanded Polytetrafluoroethylene Conduits With a Fan-Shaped Valve and Bulging Sinuses for Right Ventricular Outflow Tract Reconstruction.

Eijiro Yamashita1, Masaaki Yamagishi2, Takako Miyazaki1, Yoshinobu Maeda1, Yusuke Yamamoto3, Nobuyasu Kato1, Satoshi Asada1, Hisayuki Hongu1, Hitoshi Yaku4.   

Abstract

BACKGROUND: One of the critical factors limiting conduit longevity in right ventricular outflow tract (RVOT) reconstruction with homografts and xenografts is the small size of the conduit. The aim of our study was to assess the outcome of using smaller-sized expanded polytetrafluoroethylene (ePTFE) conduits with a fan-shaped valve and bulging sinuses for RVOT reconstruction.
METHODS: This retrospective review examined 303 patients who underwent RVOT reconstruction with ePTFE conduits at 63 Japanese hospitals between 2003 and 2014. Inclusion criteria were a conduit size less than or equal to 16 mm and the use of operative treatment as the primary correction for underlying heart disease. Patients undergoing palliative procedures were excluded.
RESULTS: Median follow-up was 1.7 years. Freedom from conduit replacement and freedom from conduit reintervention were 90.1% ± 4.8% and 77.2% ± 5.6%, respectively. The most common indication for conduit reintervention was pulmonary artery (PA) bifurcation stenosis (82%). Modeling z-scores as a dichotomous variable revealed that freedom from conduit reintervention for PA bifurcation stenosis was significantly decreased for conduits with a z-score greater than or equal to 1.4 compared with z-scores less than 1.4 (p = 0.036). There were 30 patients (9.9%) who experienced at least moderate conduit stenosis and 21 patients (6.9%) with at least moderate conduit insufficiency. Univariate Cox regression analysis showed that conduit size was a significant factor for conduit stenosis (p = 0.006).
CONCLUSIONS: Excellent midterm outcomes were achieved with ePTFE valved conduits, even when using smaller sizes. Conduit z-scores around 1.4 were optimal for RVOT reconstruction in younger patients.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27173066     DOI: 10.1016/j.athoracsur.2016.03.027

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  An immobilized liquid interface prevents device associated bacterial infection in vivo.

Authors:  Jiaxuan Chen; Caitlin Howell; Carolyn A Haller; Madhukar S Patel; Perla Ayala; Katherine A Moravec; Erbin Dai; Liying Liu; Irini Sotiri; Michael Aizenberg; Joanna Aizenberg; Elliot L Chaikof
Journal:  Biomaterials       Date:  2016-09-30       Impact factor: 12.479

Review 2.  Evolution of pulmonary valve reconstruction with focused review of expanded polytetrafluoroethylene handmade valves.

Authors:  Te-I Chang; Kang-Hong Hsu; Shao-Jung Li; Min-Kai Chuang; Chi-Wen Luo; Yi-Jen Chen; Chung-I Chang
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19

3.  0.1 mm ePTFE versus autologous pericardium for hand-sewn trileaflet valved conduit: a comparative study.

Authors:  Huifeng Zhang; Ming Ye; Gang Chen; Bing Jia
Journal:  J Artif Organs       Date:  2019-06-01       Impact factor: 1.731

4.  Hand-Made Polytetrafluoroethylene Tricuspid-Valved Conduit for Surgical Reconstruction of the Right Ventricular Outflow Tract in a Child With Truncus Arteriosus.

Authors:  Vishal V Bhende; Tanishq S Sharma; Hardil P Majmudar; Krishnan Ganapathy Subramaniam; Deepakkumar V Mehta; Amit Kumar; Purvi R Patel; Gurpreet Panesar; Kunal Soni; Kartik B Dhami; Nirja Patel; Sohilkhan R Pathan
Journal:  Cureus       Date:  2022-07-20

5.  Decellularized bovine jugular vein and hand-sewn ePTFE valved conduit for right ventricular outflow tract reconstruction in children undergoing Ross procedure.

Authors:  Haoyong Yuan; Ting Lu; Zhongshi Wu; Yifeng Yang; Jinlan Chen; Qin Wu; Sijie Wu; Hong Zhang; Tao Qian; Can Huang
Journal:  Front Cardiovasc Med       Date:  2022-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.